West Oak Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-75
Closed -$12K 391
2021
Q2
$12K Sell
75
-25
-25% -$4.17K ﹤0.01% 268
2021
Q1
$15K Sell
100
-50
-33% -$6.79K 0.01% 252
2020
Q4
$19K Hold
150
0.01% 222
2020
Q3
$15K Hold
150
0.01% 213
2020
Q2
$15K Hold
150
0.01% 225
2020
Q1
$12K Hold
150
0.01% 218
2019
Q4
$17K Hold
150
0.01% 217
2019
Q3
$15K Hold
150
0.01% 222
2019
Q2
$15K Hold
150
0.01% 233
2019
Q1
$17K Hold
150
0.01% 224
2018
Q4
$13.8K Hold
150
0.01% 230
2018
Q3
$16.5K Hold
150
0.01% 240
2018
Q2
$14K Hold
150
0.01% 243
2018
Q1
$12.4K Sell
150
-50
-25% -$4.44K 0.01% 261
2017
Q4
$18.2K Hold
200
0.01% 218
2017
Q3
$15.2K Sell
200
-100
-33% -$7.56K 0.01% 254
2017
Q2
$22.5K Hold
300
0.01% 226
2017
Q1
$19.6K Hold
300
0.01% 248
2016
Q4
$16.5K Buy
300
+100
+50% +$5.49K 0.01% 251
2016
Q3
$11.3K Buy
+200
New +$9.81K 0.01% 290

Other funds holding PRAH

West Oak Capital's PRAH Position: Q3 2021 in Review

West Oak Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 75 shares — an estimated $12K sold.

West Oak Capital first reported a position in PRAH in Q3 2016 and held it in 20 quarters. The position peaked at $22.5K in Q2 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • West Oak Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • West Oak Capital sold 75 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $12K.
  • West Oak Capital first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 20 quarters.
  • West Oak Capital's PRA Health Sciences, Inc. position peaked at $22.5K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on West Oak Capital's 13F filing for Q3 2021, filed 7 Oct 2021.